The Need for a Mycoses Reporting System

  • Carlyn Halde
  • Miriam Valesco
  • Martha Flores
Part of the Current Topics in Medical Mycology book series (CT MYCOLOGY, volume 4)


In recent years, human fungal infections have taken on a new dimension. Many fungi that previously were considered normal flora, colonists, or environmental saprobes now threaten the lives of individuals, particularly those individuals with underlying debilitating diseases. These compromised individuals, when infected by any systemic fungal pathogen, are likely to develop disseminated disease. The rapidity of invasiveness of some of the opportunists, the paucity of effective, nontoxic antifungal drugs, and the lack of vaccines are serious challenges to the health of a growing segment of the population. These individuals and communities suffering from serious systemic or opportunistic mycoses impact immediately on health care systems. The extent of this impact, nationally, is largely unknown due to the lack of a national mycoses reporting system.


Human Immunodeficiency Virus Antifungal Drug Systemic Mycosis Public Health Laboratory Opportunistic Mycosis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Brodsky AL, Gregg MB, Loewenstein MS, et al. Outbreak of histoplasmosis associated with the 1970 Earth Day activities. Am J Med 54: 333–342, 1973.PubMedCrossRefGoogle Scholar
  2. 2.
    Hammerman KJ, Powell KE, Tosh FE. The incidence of hospital cases of systemic mycotic infections. Sabouraudia, 12: 33–45, 1974.PubMedCrossRefGoogle Scholar
  3. 3.
    Fraser DW, Ward JL, Ajello L, et al. Aspergillosis and other systemic mycoses. JAMA 242: 1631–1635, 1979.PubMedCrossRefGoogle Scholar
  4. 4.
    Harrell ER, Honeycutt WM. Coccidioidomycosis: A traveling fungus disease.Arch. Dermatol. 87: 188–196, 1983.Google Scholar
  5. 5.
    Minamoto G, Armstrong D. Fungal infections in AIDS. Histoplasmosis and Coccidioidomycosis. Infect Dis Clin North Am, 2: 447–456, 1988.PubMedGoogle Scholar
  6. 6.
    CDC. Revision of the CDC Surveillance case definition for acquired immunodeficiency syndrome. MMWR 36 (no. S1): 1–9, 1987.Google Scholar
  7. 7.
    National Committee for Clinical Laboratory Standards . 1985. Antifungal susceptibility testing; Committee Report. NCCLS publication M20-CR. Villanova, PA: NCCLS.Google Scholar

Copyright information

© Springer-Verlag New York Inc. 1992

Authors and Affiliations

  • Carlyn Halde
  • Miriam Valesco
  • Martha Flores

There are no affiliations available

Personalised recommendations